Skip to main navigation Skip to search Skip to main content

Single cell transcriptome revealed tumor associated antigen (TAA) profile in lung adenocarcinoma (LUAD)

  • Fang Lv
  • , Xueying Wu
  • , Jin Song
  • , Pan Wang
  • , Shucheng Ren
  • , Wei Guo
  • , Qi Xue*
  • , Henghui Zhang*
  • , Jun Zhao*
  • *Corresponding author for this work
  • Chinese Academy of Medical Sciences
  • Capital Medical University
  • Immupeutics Medicine Institute

Research output: Contribution to journalLetterpeer-review

Abstract

It has been suggested that the heterogeneity of TAAs in lung cancer may affect the therapeutic response and disease progression. Up to now, several tumor-associated antigen (TAA)-based cancer vaccines have been investigated in lung adenocarcinoma (LUAD); however, most of them have failed at the stage of clinical trials. The present study suggests that inter-tumoral heterogeneity of TAAs is large at single-cell resolution, while the communication between tumor cells and infiltrating T cells is closely related to the expression profile of TAAs.

Original languageEnglish
Article number41
JournalBiomarker Research
Volume9
Issue number1
DOIs
Publication statusPublished - Dec 2021
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Lung adenocarcinoma
  • Single‐cell RNA sequencing
  • Tumor associated antigens

Fingerprint

Dive into the research topics of 'Single cell transcriptome revealed tumor associated antigen (TAA) profile in lung adenocarcinoma (LUAD)'. Together they form a unique fingerprint.

Cite this